Change search
ReferencesLink to record
Permanent link

Direct link
Selection and in vitro characterization of human CD44v6-binding antibody fragments
KTH, School of Biotechnology (BIO), Proteomics.ORCID iD: 0000-0002-6104-6446
2012 (English)In: Biotechnology and applied biochemistry, ISSN 0885-4513, E-ISSN 1470-8744, Vol. 59, no 5, 367-380 p.Article in journal (Refereed) Published
Abstract [en]

The cluster of differentiation (CD) 44v6 antigen has been suggested to be involved in tumor formation, invasion, and metastasis formation, and has been observed in a majority of primary and metastatic squamous cell carcinomas of the head and neck. Probes specifically binding to this region may be utilized as tools for the challenging tasks of early detection and targeted treatments of small residual disease. In this project, an epitope-guided phage display selection of human fragment antigen-binding (Fab) fragments with affinity to the v6 sequence was performed. A selected set of Fab fragments was shown to specifically recognize increasingly complex forms of the target sequence, both in the form of a short synthetic or recombinant peptide and in the context of a purified extracellular domain of CD44. The binding was independent of known v6-sequence variation and posttranslational modifications that are common in the CD44 protein family. Furthermore, real-time interaction measurements on antibody fragments labeled with 125I showed specific and high-affinity binding to the antigen present on cultured head and neck squamous cell carcinoma cells. There was no cross-reactivity toward cells that lack the target protein. As hypothesized, characterization of the interaction between Fab fragments and the targets using the mathematical tool Interaction Map revealed more heterogeneous interactions on cells than with pure proteins analyzed by surface plasmon resonance. One main candidate Fab fragment with optimal affinity for all forms of the target sequence was identified. The flexible recombinant source of the Fab fragments might aid the development of tailored molecules adapted for therapeutic or diagnostic applications in the future.

Place, publisher, year, edition, pages
2012. Vol. 59, no 5, 367-380 p.
Keyword [en]
CD44v6, Fab fragment, head and neck squamous cell carcinoma, human, Interaction Map, immunotargeting, phage display, synthetic antibody fragment
National Category
Biochemistry and Molecular Biology Medical Biotechnology
URN: urn:nbn:se:kth:diva-105672DOI: 10.1002/bab.1033ISI: 000310067800007ScopusID: 2-s2.0-84867824371OAI: diva2:572830

QC 20121129

Available from: 2012-11-29 Created: 2012-11-23 Last updated: 2012-11-29Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textScopus

Search in DiVA

By author/editor
Nilvebrant, Johan
By organisation
In the same journal
Biotechnology and applied biochemistry
Biochemistry and Molecular BiologyMedical Biotechnology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 35 hits
ReferencesLink to record
Permanent link

Direct link